Needle Free Injections - Medical Devices Pipeline Assessment, 2018

  • ID: 4580377
  • Report
  • 146 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Boston Scientific Corp
  • Crossject SA
  • Enable Injections Inc
  • Enesi Pharma Ltd
  • Eternity Healthcare Inc.
  • MORE
Needle Free Injections - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Needle Free Injections - Medical Devices Pipeline Assessment, 2018" provides an overview of Needle Free Injections currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Needle Free Injections pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Needle Free Injections under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Needle Free Injections under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Boston Scientific Corp
  • Crossject SA
  • Enable Injections Inc
  • Enesi Pharma Ltd
  • Eternity Healthcare Inc.
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Needle Free Injections Overview

3 Products under Development
3.1 Needle Free Injections - Pipeline Products by Stage of Development
3.2 Needle Free Injections - Pipeline Products by Territory
3.3 Needle Free Injections - Pipeline Products by Regulatory Path
3.4 Needle Free Injections - Pipeline Products by Estimated Approval Date
3.5 Needle Free Injections - Ongoing Clinical Trials

4 Needle Free Injections - Pipeline Products under Development by Companies
4.1 Needle Free Injections Companies - Pipeline Products by Stage of Development
4.2 Needle Free Injections - Pipeline Products by Stage of Development

5 Needle Free Injections Companies and Product Overview
5.1 B. Braun Melsungen AG Company Overview
5.2 Boston Scientific Corp Company Overview
5.3 Crossject SA Company Overview
5.4 Enable Injections Inc Company Overview
5.5 Enesi Pharma Ltd Company Overview
5.6 Eternity Healthcare Inc. Company Overview
5.7 Inovio Pharmaceuticals Inc Company Overview
5.8 Medical International Technologies (Mit Canada) Inc Company Overview
5.9 PharmaJet Inc Company Overview
5.10 Queen's University Company Overview
5.11 Takeda Pharmaceutical Co Ltd Company Overview
5.12 Teva Pharmaceutical Industries Ltd Company Overview

6 Needle Free Injections- Recent Developments
6.1 Jun 08, 2018: B. Braun to Showcase Its Commitment to Reducing Healthcare-Associated Infections with Products and Education at APIC 2018
6.2 Jun 06, 2018: Daiichi Sankyo's U.S. Products Liability Litigation Settlement Program Moves Forward; More than 97 Percent of Eligible Litigants and Claimants Opt In
6.3 May 30, 2018: Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET Needle-Free Delivery System
6.4 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference
6.5 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
6.6 May 11, 2018: Daiichi Sankyo Announces Changes to Representative Directors and Members of the Audit and Supervisory Board
6.7 May 09, 2018: ICU Medical Announces First Quarter 2018 Results
6.8 May 08, 2018: Antares Pharma Reports First Quarter 2018 Operating and Financial Results
6.9 May 03, 2018: Teva Reports First Quarter 2018 Financial Results
6.10 May 01, 2018: Merck Announces First-Quarter 2018 Financial Results
6.11 Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018
6.12 Apr 26, 2018: Consort Medical: Director Declaration
6.13 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.14 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang
6.15 Apr 17, 2018: Vaccibody moving forward with Cancer Neoantigen Vaccine Trial
6.16 Mar 23, 2018: Aradigm Reports Fourth Quarter 2017 And Full Year Financial Results
6.17 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros
6.18 Mar 20, 2018: Merck Names Jennifer Zachary As General Counsel
6.19 Mar 13, 2018: Phase 1 clinical trial for Hantavirus vaccines yields positive interim results
6.20 Mar 01, 2018: Antares Pharma Announces Receipt of Second Installment from Sale of Zomajet Needle-Free Delivery System
6.21 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results
6.22 Feb 28, 2018: Daiichi Sankyo Aligns U.S. Commercial Operations to Current Portfolio and Upcoming Cancer Pipeline
6.23 Feb 23, 2018: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2018
6.24 Feb 21, 2018: Daiichi Sankyo Selected for 2018 Certified Health and Productivity Management Organization (White 500)
6.25 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program
6.26 Feb 09, 2018: Aradigm Announces Personnel Changes
6.27 Feb 08, 2018: Teva Reports 2017 Full Year and Fourth Quarter Financial Results
6.28 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.29 Feb 06, 2018: Vaccibody Expands Human Clinical Trial of HPV Vaccine
6.30 Feb 06, 2018: Teva Pharmaceuticals laid off 46 employees in Parsippany
6.31 Feb 02, 2018: Daiichi Sankyo Selected for Silver Class of RobecoSAM Sustainability Award 2018
6.32 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.33 Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results
6.34 Jan 31, 2018: Ferring's ZOMACTON (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults
6.35 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.36 Jan 24, 2018: Merck Names Inge Thulin To Board Of Directors
6.37 Jan 23, 2018: LENIS Needle-Free Injection System Signs U.S. Exclusive With LenisUSA.com
6.38 Jan 23, 2018: Study shows superiority of PharmaJet Needle-free Injector for poliovirus vaccine administration
6.39 Jan 19, 2018: Teva Layoffs To Affect 65 Employees In Horsham, North Wales
6.40 Jan 18, 2018: B. Braun to Showcase Comprehensive Parenteral Nutrition Program, New Compounder and More at ASPEN
6.41 Jan 09, 2018: Zika Virus vaccine shows significantly higher immune response with Needle-free delivery
6.42 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.43 Jan 09, 2018: Valeritas Appoints Joseph Saldanha as Chief Business Officer

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Needle Free Injections - Pipeline Products by Stage of Development
Table 2: Needle Free Injections - Pipeline Products by Territory
Table 3: Needle Free Injections - Pipeline Products by Regulatory Path
Table 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
Table 5: Needle Free Injections - Ongoing Clinical Trials
Table 6: Needle Free Injections Companies - Pipeline Products by Stage of Development
Table 7: Needle Free Injections - Pipeline Products by Stage of Development
Table 8: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Needle-Free System - Product Status
Table 10: Needle-Free System - Product Description
Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 12: JetTouch System - Overactive Bladder - Product Status
Table 13: JetTouch System - Overactive Bladder - Product Description
Table 14: Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Zeneo ID Human Needle-Free Injection Device - Product Status
Table 16: Zeneo ID Human Needle-Free Injection Device - Product Description
Table 17: Zeneo IM 0.5ml Needle - Free Injection Device - Product Status
Table 18: Zeneo IM 0.5ml Needle - Free Injection Device - Product Description
Table 19: Zeneo SC 0.5ml Needle-Free Injection Device - Product Status
Table 20: Zeneo SC 0.5ml Needle-Free Injection Device - Product Description
Table 21: Zeneo SC 0.8ml Needle-Free Injection Device - Product Status
Table 22: Zeneo SC 0.8ml Needle-Free Injection Device - Product Description
Table 23: Zeneo SC High Viscosity Needle-Free Injection Device - Product Status
Table 24: Zeneo SC High Viscosity Needle-Free Injection Device - Product Description
Table 25: Enable Injections Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Enable Smart enFuse - Product Status
Table 27: Enable Smart enFuse - Product Description
Table 28: Enesi Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Enesi SDI - Product Status
Table 30: Enesi SDI - Product Description
Table 31: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Multi Channel Needle-Free Injection Device - Product Status
Table 33: Multi Channel Needle-Free Injection Device - Product Description
Table 34: Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Iject R Pre-Filled Syringe - Product Status
Table 36: Iject R Pre-Filled Syringe - Product Description
Table 37: Intradermal Pen Injector - Product Status
Table 38: Intradermal Pen Injector - Product Description
Table 39: Intradermal Syringe - Product Status
Table 40: Intradermal Syringe - Product Description
Table 41: Mega Jet - Product Status
Table 42: Mega Jet - Product Description
Table 43: Multi-Port Orifices - Product Status
Table 44: Multi-Port Orifices - Product Description
Table 45: Needle-Free Vaccine Delivery Device - Product Status
Table 46: Needle-Free Vaccine Delivery Device - Product Description
Table 47: Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: MED-JET MBX Injector - Product Status
Table 49: MED-JET MBX Injector - Product Description
Table 50: MIT-H-III - Product Status
Table 51: MIT-H-III - Product Description
Table 52: MIT-H-IV-1 - Product Status
Table 53: MIT-H-IV-1 - Product Description
Table 54: MIT-H-IV-5 - Product Status
Table 55: MIT-H-IV-5 - Product Description
Table 56: MIT-H-VI Dental Injector - Product Status
Table 57: MIT-H-VI Dental Injector - Product Description
Table 58: PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Tropis - Product Status
Table 60: Tropis - Product Description
Table 61: Variable Volume Drug Delivery Device - Product Status
Table 62: Variable Volume Drug Delivery Device - Product Description
Table 63: PharmaJet Inc - Ongoing Clinical Trials Overview
Table 64: Tropis - A First in Human Phase I Study of INVAC-1 as a Single Agent in Patients with Advanced Cancer
Table 65: Tropis - A Phase II Study of INVAC-1 as Treatment of Patients With High-risk Chronic Lymphocytic Leukemia
Table 66: Tropis - A Pragmatic Trial to Quantitatively and Qualitatively Assess Different Techniques for the ID Administration of Fractional Dose IPV in a Campaign Setting in the Gambia
Table 67: Tropis - A Randomized, Parallel Design Study to Compare the Safety and Effectiveness of Gardasil When Delivered per Standard Practice (Full Dose, Intramuscular (IM) Delivery Using a Needle and Syringe) Vs. Full Dose, IM Delivery via Needle-free Jet Injection or Reduced Dose, Intradermal Delivery via Needle-free Jet Injection
Table 68: Queen's University Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Hydrogel-Based Microneedle - Product Status
Table 70: Hydrogel-Based Microneedle - Product Description
Table 71: Takeda Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Needle-Free Drug Delivery Device - Product Status
Table 73: Needle-Free Drug Delivery Device - Product Description
Table 74: Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 75: MicroDose Needlefree System - Product Status
Table 76: MicroDose Needlefree System - Product Description
Table 77: Glossary

List of Figures
Figure 1: Needle Free Injections - Pipeline Products by Stage of Development
Figure 2: Needle Free Injections - Pipeline Products by Territory
Figure 3: Needle Free Injections - Pipeline Products by Regulatory Path
Figure 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
Figure 5: Needle Free Injections - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Boston Scientific Corp
  • Crossject SA
  • Enable Injections Inc
  • Enesi Pharma Ltd
  • Eternity Healthcare Inc.
  • Inovio Pharmaceuticals Inc
  • Medical International Technologies (Mit Canada) Inc
  • PharmaJet Inc
  • Queen's University
  • Takeda Pharmaceutical Co Ltd
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll